Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NSE/AKUMS stock hub

NSE/AKUMS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/AKUMSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

85.3B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/AKUMS

In the news

Latest news · NSE/AKUMS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E24.3

P25 24.9P50 32.4P75 45.7

Trailing P/E26.8

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC19.3

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/AKUMS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

159

Groups with data

Currency

INR

Showing 159 of 159 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	7,536
Employees Change	148%
Employees Change Percent	2
Enterprise value	INR 69.8B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	INE09XN01023
Last refreshed	2026-05-10
Market cap	INR 85.3B
Price	INR 558
Price currency	INR
Rev Per Employee	5,652,427.02x
Sector	Healthcare
Sic	2834
Symbol	nse/AKUMS
Website	https://www.akums.in

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.73%
EV Earnings	21.95x
EV/EBIT	21.75x
EV/EBITDA	14.25x
EV/Sales	1.64x
Forward P/E	24.27x
P/B ratio	2.69x
P/E ratio	26.81x
P/S ratio	2x
PEG ratio	1.45x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	7.54%
EBITDA Margin	11.21%
Gross margin	39.95%
Gross Profit	INR 17B
Gross Profit Growth	7.94%
Gross Profit Growth Q	17.89%
Gross Profit Growth3 Y	10.51%
Net Income	INR 3.2B
Net Income Growth	113.21%
Net Income Growth Q	1.74%
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Pretax Margin	7.89%
Profit Margin	7.47%
Profit Per Employee	INR 422,229
Profitable Years	1
ROIC	19.34
Roic5y	22.76

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	8.96%
EPS Growth	105
EPS Growth Q	1.64
EPS Growth Quarters	1
EPS Growth Years	1
Revenue Growth	6.22x
Revenue Growth Q	14.76x
Revenue Growth Quarters	1x
Revenue Growth Years	2x
Revenue Growth3 Y	5.04x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 16.5B
Debt	INR 902.9M
Debt EBITDA	INR 0.18
Debt Equity	INR 0.03
Equity	INR 31.7B
Interest Coverage	4.55
Net Cash	INR 15.6B
Net Cash By Market Cap	INR 18.34
Net Cash Growth	491.33%
Net Debt EBITDA	INR -3.28
Net Debt Equity	INR -0.49
Tangible Book Value	INR 31.4B
Tangible Book Value Per Share	INR 205

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.01%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	8.95%
200-day SMA	471
50-day SMA	504.3
50-day SMA vs 200-day SMA	50over200
All Time High	1,175.9
All Time High Change	-52.54%
All Time High Date	2024-08-20
All Time Low	405
All Time Low Change	37.79%
All Time Low Date	2025-04-07
ATR	17.73
Beta1y	0.44
Beta2y	0.95
Ch YTD	23.08
High	561
High52	623
High52 Date	2025-05-27
High52ch	-10.42%
Low	546.8
Low52	409.3
Low52 Date	2026-01-21
Low52ch	36.34%
Ma50ch	10.67%
Price vs 200-day SMA	18.48%
RSI	61.96
RSI Monthly	40.59
RSI Weekly	65.48
Sharpe ratio	0.26x
Sortino ratio	0.62
Total Return	-4.01%
Tr YTD	23.08
Tr1m	13.99%
Tr1w	-0.2%
Tr3m	24.87%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 3.2B
Operating Income Growth	3.1
Operating Income Growth Q	39.51
Operating Income Growth3 Y	0.55
Operating margin	7.54

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	34,646,578%
Shares Insiders	35.44%
Shares Institutions	16.98%
Shares Out	153,102,058
Shares Qo Q	-0.11%
Shares Yo Y	4.01%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	200,306.7x
Bv Per Share	205.4
Ch1m	13.99
Ch1w	-0.2
Ch1y	8.95
Ch3m	24.87
Ch6m	23.1
Change	1.83%
Change From Open	2.06
Close	548
Days Gap	-0.22
Depreciation Amortization	1,564,212,500
Dollar Volume	90,314,252.3
Earnings Date	2026-05-26
EBIT	INR 3.2B
EBITDA	INR 4.8B
EPS	INR 20.78
F Score	2
Fiscal Year End	March
Founded	2,004
Graham Number	309.8557
Graham Upside	-44.48
Income Tax	INR 113.6M
Is Primary Listing	1
Last Earnings Date	2026-02-13
Last Report Date	2025-12-31
Ma150	464.2
Ma150ch	20.21%
Ma20	537.4
Ma20ch	3.84%
Next Earnings Date	2026-05-26
Open	546.8
Position In Range	79.23
Price Date	2026-05-08
Price EBITDA	INR 17.86
Ptbv Ratio	2.72
Relative Volume	0.8x
Revenue	42,596,690,000x
Tax By Revenue	0.27x
Tax Rate	3.38%
Tr6m	23.1%
Volume	161,839

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NSE/AKUMS pay a dividend?

Capital-return profile for this ticker.

Performance

NSE/AKUMS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/AKUMS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+17.0%

Share of float held by funds and institutions

Insider ownership

+35.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+4.0%

Negative means the company is buying back shares.

Technical

NSE/AKUMS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

62.0

Neutral momentum band

Price vs 200-day MA

+18.5%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.26

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/AKUMS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/AKUMS stock rating?

nse/AKUMS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/AKUMS analysis?

The full report lives at /stocks/nse/AKUMS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/AKUMS?

The latest report frames nse/AKUMS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/AKUMS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.